Joaquin E Cigarroa, Jennifer S Lawton, Dinesh Kalra, Dipti Itchhaporia, Jacqueline E Tamis-Holland, Diana Baptiste, Marlene S Williams, Timothy D Henry, Glenn N Levine, Anandita Agarwala, Kelly C Rogers, Martha Gulati, L Kristin Newby, Rebecca L Diekemper, Marva V Foster, Krishan Soni
Journal: Journal of the American College of Cardiology 2025;85(25):2504-2535
PMID: 40310322
Chronic coronary disease (CCD) is the leading cause of death in the United States. There is an ongoing imperative to disseminate evidence-based and patient-centered care recommendations that further align the management of patients with CCD to updated evidence-based guidelines. The writing committee developed a comprehensive CCD measure set comprising 10 performance measures and 3 quality measures, the focus of which is to include practical steps to specifically advance care in the CCD population. The measure set begins with an assessment of tobacco use and evidence-based cessation interventions. Also included are topics such as antiplatelet therapy, lipid assessment and low-density lipoprotein cholesterol goals, and guideline-directed management and therapy for hypertension and reduced left ventricular dysfunction in patients with CCD. The measure set concludes with an emphasis on the importance of cardiac rehabilitation referral and patient education, including symptom management and lifestyle modification.
Copyright © 2025 American Heart Association, Inc and American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.